Company
Olema Oncology
Developing Better Medicines for Breast Cancer and Beyond
Also known as Olema Pharmaceuticals, Olema Pharmaceuticals, Inc.
- Business model
- B2B
- Headquarters
- San Francisco, California, United States
- Founded
- 2006
- Legal name
- Olema Pharmaceuticals, Inc.
- olema.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Olema is a clinical-stage biopharmaceutical company focused on transforming the metastatic breast cancer treatment paradigm and improving outcomes for patients living with breast cancer and beyond. We are advancing our pipeline of novel therapies by leveraging our deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance.
Funding snapshot
- Total raised
- $527MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $250M2024-12-04
Funding rounds
- Round, 2024
- $250M2024-12-04, SEC form D sold, 26 investors
- Round, 2023
- $130M2023-09-05, SEC form D sold, 12 investors
- Round, 2020
- $87.4M2020-09-30, SEC form D sold, 27 investors
- Round, 2020
- $53.9M2020-03-13, SEC form D sold, 16 investors
- Round, 2018
- $6.1M2018-07-19, SEC form D sold, 13 investors
Loading relationship preview